Related Experiment Video
Updated: Jun 16, 2025

Purification of the Membrane Compartment for Endoplasmic Reticulum-associated Degradation of Exogenous Antigens in Cross-presentation
Published on: August 21, 2017
Outer Membrane Vesicles from Caulobacter crescentus: A Platform for Recombinant Antigen Presentation
Luis David Ginez1, Aurora Osorio1, Víctor Correal-Medina1
1Departamento de Biología Molecular y Biotecnologia, Instituto de Investigaciones Biomédicas, Universidad Nacional Autónoma de México, Instituto de Investigaciones Biomédicas, Circuito Mario de la Cueva s/n, Ciudad Universitaria, Ciudad de México 04510, México.
Bacterial outer membrane vesicles (OMVs) from Caulobacter crescentus offer a safe and effective vaccine platform. These OMVs show reduced inflammation and can present antigens, enabling low-cost vaccine development.
Area of Science:
- Biotechnology
- Vaccinology
- Microbiology
Background:
- Bacterial outer membrane vesicles (OMVs) are promising vaccine candidates due to their adjuvant properties, size, acellularity, and cost-effectiveness.
- However, OMVs can cause severe inflammatory responses and are produced in low yields, limiting their vaccine application.
Purpose of the Study:
- To engineer Caulobacter crescentus for enhanced OMV production.
- To evaluate the safety and efficacy of C. crescentus-derived OMVs as a vaccine platform compared to Escherichia coli K-12 OMVs.
Main Methods:
- Engineered C. crescentus for high OMV yield.
- Assessed OMV inflammatory potential in murine models and human cell assays.
- Loaded OMVs with recombinant proteins and evaluated immunogenicity in vivo.
Main Results:
- Engineered C. crescentus strain demonstrated high OMV yields.
- C. crescentus OMVs induced significantly lower inflammatory responses than E. coli K-12 OMVs.
- OMVs efficiently presented recombinant antigens, eliciting antibody production with adjuvant effects.
Conclusions:
- C. crescentus OMVs represent a safe and effective platform for vaccine development.
- This approach facilitates the creation of low-cost vaccines with reduced inflammatory potential.
More Related Videos
08:07A "Plug-And-Display" Nanoparticle Vaccine Platform Based on Outer Membrane Vesicles Displaying SARS-CoV-2 Receptor-Binding Domain
Published on: July 25, 2022
12:53Cell-Free Scaled Production and Adjuvant Addition to a Recombinant Major Outer Membrane Protein from Chlamydia muridarum for Vaccine Development
Published on: March 16, 2022
Related Concept Videos
Intralumenal Vesicles and Multivesicular Bodies
Clathrin Coated Vesicles
Vesicular Tubular Clusters
With the help of motor proteins such...
Antigen Processing Pathways
MHC Class I: Presenting Endogenous...
Overview of Secretory Vesicles
Various proteins regulate the aggregation of molecules inside the secretory vesicles. Chromogranins...
Antigen Presenting Cells
T cells require the help of antigen-presenting cells (APCs), which process foreign antigens into smaller fragments that can be recognized by T cells. These APCs are highly specialized cells that efficiently internalize antigens...